Lataa...
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients
OBJECTIVE: To assess the effect of anti-CD20 B-cell depletion with rituximab (RTX) on relapse rates in myelin oligodendrocyte glycoprotein antibody-associated disorder (MOGAD). METHODS: Retrospective review of RTX-treated MOGAD patients from 29 centres in 13 countries. The primary outcome measure wa...
Tallennettuna:
| Julkaisussa: | Mult Scler Relat Disord |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7895306/ https://ncbi.nlm.nih.gov/pubmed/32629363 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.msard.2020.102251 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|